Effect of leukotriene antagonist on experimental and clinical bronchial asthma.
Nakagawa
T
T
Department of Internal Medicine, St. Marianna University, School of Medicine, Kawasaki, Japan.
Mizushima
Y
Y
Ishii
A
A
Nambu
F
F
Motoishi
M
M
Yui
Y
Y
Shida
T
T
Miyamoto
T
T
D000485:Allergens; D000707:Anaphylaxis / Q000139:chemically induced / Q000517:prevention & control; D000818:Animals; D001249:Asthma / Q000188:drug therapy*; D001980:Bronchi / Q000187:drug effects; D001985:Bronchial Provocation Tests; D002867:Chromones / Q000494:pharmacology* / Q000627:therapeutic use; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D004391:Dust; D006168:Guinea Pigs; D006632:Histamine; D006801:Humans; D007116:Immunization, Passive; D007213:Indomethacin / Q000494:pharmacology; D008297:Male; D010047:Ovalbumin / Q000633:toxicity; D011738:Pyrilamine / Q000494:pharmacology; D013189:SRS-A / Q000037:antagonists & inhibitors*
D000485:Allergens; D002867:Chromones; D004391:Dust; D013189:SRS-A; D006632:Histamine; C006312:FPL 55712; D010047:Ovalbumin; D011738:Pyrilamine; C047681:pranlukast; D007213:Indomethacin